Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-66,200
Closed -$4.59M 1772
2022
Q2
$4.59M Sell
66,200
-7,300
-10% -$542K 0.04% 378
2022
Q1
$5.65M Buy
+73,500
New +$5.29M 0.04% 381
2018
Q4
Sell
-31,500
Closed -$1.29M 2317
2018
Q3
$1.29M Buy
+31,500
New +$1.27M 0.01% 1203
2018
Q1
Sell
-1,200
Closed -$51K 2438
2017
Q4
$51K Sell
1,200
-63,700
-98% -$2.54M ﹤0.01% 2376
2017
Q3
$2.38M Buy
+64,900
New +$2.62M 0.02% 859
2016
Q2
Sell
-50,000
Closed -$1.73M 2259
2016
Q1
$1.73M Buy
+50,000
New +$1.74M 0.01% 914
2013
Q4
Sell
-118,100
Closed -$2.44M 2042
2013
Q3
$2.44M Sell
118,100
-182,900
-61% -$3.89M 0.02% 535
2013
Q2
$5.81M Buy
+301,000
New +$6.29M 0.06% 224

Other funds holding HOLX

Jefferies Group's HOLX Position: Q3 2022 in Review

Jefferies Group increased its Hologic (HOLX) stake by 14,107% in Q3 2022, buying an estimated $4.79M and bringing the position to 69,614 shares worth $4.49M. The position accounts for 0.04% of the portfolio, ranked #370.

Jefferies Group first reported a position in HOLX in Q2 2013 and has held it in 29 quarters since. The position peaked at $9.96M in Q1 2022. 653 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Jefferies Group held 69,614 shares of Hologic worth $4.49M as of Q3 2022.
  • Jefferies Group bought 69,124 Hologic shares in Q3 2022, an estimated $4.79M.
  • Hologic made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #370 holding.
  • Jefferies Group first reported a position in Hologic in Q2 2013 and has held it in 29 quarters since.
  • Jefferies Group's Hologic position peaked at $9.96M in Q1 2022.
  • 653 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.